Meibomian gland dysfunction

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
S Ophthalmology/ENT (ATC S) 1
Mechanism of action (INN-stem analysis)
Corticosteroid 1 substance
Phase IV: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase IV

1 trial
  • Laboratorios Lesvi S.L. Commercial
    HYDROCORTISONE SODIUM PHOSPHATE
    2024-518093-13-00 1 country 2021 n=54
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Laboratorios Lesvi S.L. Commercial 1 Phase IV 0
New trials by year
2021
1
← All indication landscapes